4 completed, 3 terminated, 2 recruiting, 1 active not recruiting. 11 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 4, Terminated 3, Recruiting 2, Active not recruiting 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Neuritis: new trials by email Literature Review of Neuritis trials Research Report on Neuritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection, Dolutegravir (DTG) - HTLV-1 Infection, HTLV I Associated Myelopathies | Phase 2 | Recruiting | Carlos Brites | 146 | 2026-05-07 | 2026-06-02 |
| IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies Panzyga IVIG, Placebo - Small Fiber Neuropathy, Autoimmune Small Fiber Neuropathy | Phase 2 | Recruiting | Endeavor Health | 20 | 2023-12-15 | 2026-01-09 |
| ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy Acalabrutinib, Rituximab - IgM MGUS, Waldenstrom Macroglobulinemia | Phase 2 | Active not recruiting | Shayna Sarosiek, MD | 12 | 2021-11-16 | 2025-12-05 |
| Exercise and Nutrition Interventions During Chemotherapy K07 EXCAP Exercise, Nutrition Education - Neuropathy;Peripheral | Phase 2 | Completed | University of Rochester | 80 | 2019-04-15 | 2025-12-22 |
| The Effect of Lacosamide in Peripheral Neuropathic Pain Lacosamide, Placebo - Neuropathic Pain, Neuropathy;Peripheral | Phase 2 | Terminated | Danish Pain Research Center | 63 | 2019-01-15 | 2023-02-16 |
| Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis CNM-Au8, Placebo - Relapsing Remitting Multiple Sclerosis, Optic Neuropathy | Phase 2 | Terminated | Clene Nanomedicine | 73 | 2018-11-23 | 2023-04-03 |
| Micro-mobile Foot Compression and Diabetic Foot Avex Footbeat - Diabetes, PAD | Phase 2 | Completed | Baylor College of Medicine | 30 | 2017-05-02 | 2021-10-28 |
| Hypoalgesic Effect of Neural Mobilization Versus Ibuprofen Pharmacologic Treatment Median Nerve Neural Mobilization, Ibuprofen - Cervicobrachial Neuralgia | Phase 2 / Phase 3 | Completed | Universidad Europea de Madrid | 50 | 2015-07-01 | 2017-01-04 |
| Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve Amiloride hydrochlorothiazide, Sugar pill - Optic; Neuritis, With Demyelination | Phase 2 | Unknown | Medical University of Vienna | 78 | 2014-03-01 | 2015-05-12 |
| Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis Nerispirdine, Placebo - Multiple Sclerosis, Optic Nerve | Phase 2 | Completed | Sanofi | 31 | 2008-09-01 | 2016-02-26 |
| Atacicept in Subjects With Optic Neuritis Atacicept, Placebo matched to atacicept - Optic Neuritis | Phase 2 | Terminated | EMD Serono | 34 | 2008-06-01 | 2016-02-17 |
Brachial Plexus Neuritis (1) · Demyelinating Diseases (1) · Diabetes Mellitus (1) · Diabetic Foot (1) · Diabetic Neuropathies (1) · HTLV-I Infections (1) · Leukemia-Lymphoma, Adult T-Cell (1) · Lymphatic Diseases (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Neuralgia (1) · Neuropathy, Painful (1) · Optic Nerve Diseases (1) · Optic Neuritis (1)
Nervous System Diseases (11) · Neuromuscular Diseases (11) · Peripheral Nervous System Diseases (11) · Immune System Diseases (4) · Hemic and Lymphatic Diseases (3) · Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Cardiovascular Diseases (2) · Cranial Nerve Diseases (2) · Demyelinating Autoimmune Diseases, CNS (2) · Diabetes Complications (2) · Endocrine System Diseases (2) · Eye Diseases (2) · Hematologic Diseases (2) · Immunoproliferative Disorders (2)
Ibuprofen (1) · Lacosamide (1) · Midol (1) · Nutrition Assessment (1) · Rituximab (1) · Sugars (1) · TACI receptor-IgG Fc fragment fusion protein (1) · Tenofovir (1) · acalabrutinib (1) · amiloride, hydrochlorothiazide drug combination (1) · dolutegravir (1) · nerispirdine (1)
Baylor College of Medicine (1) · Carlos Brites (1) · Clene Nanomedicine (1) · Danish Pain Research Center (1) · EMD Serono (1) · Endeavor Health (1) · Medical University of Vienna (1) · Sanofi (1) · Shayna Sarosiek, MD (1) · Universidad Europea de Madrid (1) · University of Rochester (1)
United States (7) · Australia (2) · Canada (2) · Austria (1) · Belgium (1) · Brazil (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Lebanon (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · Venezuela (1)
Carlos Brites, MD, PhD (1) · Francisco H Unda, PT, MSc (1) · Fritz Leutmezer, MD (1) · Heidi Beadnall, MD (1) · Lawrence Zeidman, MD, FAAN (1) · Nanna B Finnerup, Professor (1) · Shayna R. Sarosiek, MD (1)
PMID 10606379, PMID 10846153, PMID 11735667, PMID 11884154, PMID 12151246, PMID 12723749, PMID 12918862, PMID 12973155, PMID 1509971, PMID 1542147, PMID 15784928, PMID 16436853, PMID 16448572, PMID 16848101, PMID 16862046, PMID 16967609, PMID 17413924, PMID 18209131, PMID 18316238, PMID 18482862, PMID 18495734, PMID 18827326, PMID 1894754, PMID 19119380, PMID 19119381, PMID 19251067, PMID 19345936, PMID 19465371, PMID 19487826, PMID 1989013, PMID 20052961, PMID 20091520, PMID 20128070, PMID 20436238, PMID 2052056, PMID 20961685, PMID 21075037, PMID 21216272, PMID 21561527, PMID 22317661, PMID 22341379, PMID 22471358, PMID 22588743, PMID 22711174, PMID 22786518, PMID 22818658, PMID 22839415, PMID 22851876, PMID 23024624, PMID 23115473
2018 (1), K07CA221931 (1)